TET3 and endometriosis: Recent reports further demonstrated that Bobcat339 can trigger TET3 degradation and deplete TET3-overexpressing human macrophage-induced chronic inflammatory processes, underscoring the therapeutic potential of targeting TET3 in macrophages as a strategy for managing endometriosis [49].